SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-047772
Filing Date
2014-08-07
Accepted
2014-08-07 17:07:08
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q v384836_10q.htm 10-Q 511178
2 EXHIBIT 31.1 v384836_ex31-1.htm EX-31.1 10336
3 EXHIBIT 31.2 v384836_ex31-2.htm EX-31.2 10337
4 EXHIBIT 32.1 v384836_ex32-1.htm EX-32.1 4509
5 EXHIBIT 32.2 v384836_ex32-2.htm EX-32.2 4544
  Complete submission text file 0001144204-14-047772.txt   5789803

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nvax-20140630.xml EX-101.INS 836058
7 XBRL TAXONOMY EXTENSION SCHEMA nvax-20140630.xsd EX-101.SCH 39020
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nvax-20140630_cal.xml EX-101.CAL 63028
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nvax-20140630_def.xml EX-101.DEF 185866
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvax-20140630_lab.xml EX-101.LAB 757732
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvax-20140630_pre.xml EX-101.PRE 353158
Mailing Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26770 | Film No.: 141024742
SIC: 2836 Biological Products, (No Diagnostic Substances)